PFS Partners’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
VPM
VCM
KBG
PMG
PFS Partners's OGN Position: Q1 2026 in Review
PFS Partners reduced its Organon & Co (OGN) stake by 1.5% in Q1 2026, selling an estimated $38 and leaving 321 shares worth $1.92K. The position accounts for ﹤0.01% of the portfolio, ranked #521.
PFS Partners first reported a position in OGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $9.36K in Q1 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.
- PFS Partners held 321 shares of Organon & Co worth $1.92K as of Q1 2026.
- PFS Partners sold 5 Organon & Co shares in Q1 2026, an estimated $38.
- Organon & Co made up ﹤0.01% of PFS Partners's portfolio in Q1 2026, its #521 holding.
- PFS Partners first reported a position in Organon & Co in Q4 2021 and has held it in 18 quarters since.
- PFS Partners's Organon & Co position peaked at $9.36K in Q1 2022.
- 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.
Based on PFS Partners's 13F filing for Q1 2026, filed 9 Apr 2026.